Fri Oct 24 03:11:51 SGT 2014  
    Genital Warts Treatment, Timor-Leste
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital Warts Treatment, Timor-Leste | HIV STD TESTING SINGAPORE™


Genital Warts Treatment, Timor-Leste | HIV STD TESTING SINGAPORE™ @beautytimorleste_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Timor-Leste - Private and confidential service. Definitions, references, and latest news.

Keywords: Genital Warts Treatment Timor-Leste, Timor-Leste Genital Warts Treatment, Genital Warts Treatment.


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts Treatment, Timor-Leste
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.


Latest News

Optimization of HPV DNA detection in urine by improving collection, storage, and extraction
Wed, 22 Oct 2014 16:54:14 +0100 | European Journal of Clinical Microbiology and Infectious Diseases

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
Tue, 21 Oct 2014 20:17:11 +0100 | Cancer
CONCLUSIONSThis relatively large cohort study demonstrates that a high CNC and a high CMC independently predict inferior OS and RFS, whereas a high CLC predicts better RFS and marginally better OS in HPV+ OPC patients. This association was not apparent in HPV– patients. Cancer 2014. © 2014 American Cancer Society. (Source: Cancer)

Uptake of Human Papillomavirus Vaccine Among Adolescent Males and Females: Immunization Information System Sentinel Sites, 2009–2012
Tue, 21 Oct 2014 00:00:00 +0100 | Academic Pediatrics
Conclusions HPV vaccination coverage increased among adolescents between 2009 and 2012. However, increases among girls were small, and coverage for boys and girls remained below target levels. (Source: Academic Pediatrics)

No link between vaccination and risk of MS
Mon, 20 Oct 2014 23:00:00 +0100 | Multiple Sclerosis Trust
This new study found no long term association between any vaccines, including hepatitis B and HPV (human papillomavirus), and an increased risk of developing MS, for up to three years following vaccination. (Source: Multiple Sclerosis Trust)

Human papillomavirus 66‐associated subungual squamous cell carcinoma
Mon, 20 Oct 2014 00:00:00 +0100 | The Journal of Dermatology
(Source: The Journal of Dermatology)

Distribution of high‐risk human papillomavirus genotypes in HPV‐infected women in Beijing, China
Mon, 20 Oct 2014 00:00:00 +0100 | Journal of Medical Virology
In this study, HPV 16 and HPV 52 were the most common subtypes found in patients with cervical lesions. J. Med. Virol. © 2014 Wiley Periodicals, Inc. (Source: Journal of Medical Virology)

Evidence that human papillomavirus causes inverted papilloma is sparse
Mon, 20 Oct 2014 00:00:00 +0100 | International Forum of Allergy and Rhinology
ConclusionGiven histological features of inverted papilloma and comparatively low detection rates of HPV in inverted papilloma without dysplasia (2.7%), as well as the summary of the world literature, HPV is not related to the initial pathogenesis of inverted papilloma or inverted papilloma's tendency to persist or recur. It is postulated that since inverted papilloma is more an inflammatory polyp, it is susceptible to secondary HPV infection because of its metaplasia. Tobacco and other causes of respiratory epithelium remodeling are more plausible explanations for the initial tissue transformation to inverted papilloma. (Source: International Forum of Allergy and Rhinology)

Vaccines and MS
Sun, 19 Oct 2014 23:00:00 +0100 | Multiple Sclerosis Trust
A study found no association between hepatitis B and human papillomavirus (HPV) vaccines and an increased risk of MS up to three years after vaccination.

Analysis of human papillomavirus E7 protein status in C-33A cervical cancer cells
Sun, 19 Oct 2014 00:00:00 +0100 | Virus Genes

The Estimated Impact of Human Papillomavirus Vaccine Coverage on the Lifetime Cervical Cancer Burden Among Girls Currently Aged 12 Years and Younger in the United States
Sat, 18 Oct 2014 05:10:46 +0100 | Sexually Transmitted Diseases
AbstractUsing a previously published dynamic model, we illustrate the potential benefits of human papillomavirus vaccination among girls currently 12 years or younger in the United States. Increasing vaccine coverage of young girls to 80% would avert 53,300 lifetime cervical cancer cases versus 30% coverage and 28,800 cases versus 50% coverage. (Source: Sexually Transmitted Diseases)